Greenwich LifeSciences, Inc. (GLSI) financial statements (2022 and earlier)

Company profile

Business Address 3992 BLUEBONNET DR, BUILDING 14
STAFFORD, TX 77477
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments27,20428,660
Cash and cash equivalents27,20428,660
Total current assets:27,20428,660
Noncurrent Assets
Intangible assets, net (including goodwill)1316
Intangible assets, net (excluding goodwill)1316
Total noncurrent assets:1316
TOTAL ASSETS:27,21728,677
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:221711
Employee-related liabilities16459
Other undisclosed accounts payable and accrued liabilities57652
Due to related parties 275
Other undisclosed current liabilities16459
Total current liabilities:3851,045
Noncurrent Liabilities
Total liabilities:3851,045
Stockholders' equity
Stockholders' equity attributable to parent26,83227,631
Common stock1313
Additional paid in capital60,46656,695
Accumulated deficit(33,648)(29,077)
Total stockholders' equity:26,83227,631
TOTAL LIABILITIES AND EQUITY:27,21728,677

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
Operating expenses(4,598)(1,864)
Operating loss:(4,598)(1,864)
Nonoperating income
(Investment Income, Nonoperating)
271
Net loss available to common stockholders, diluted:(4,571)(1,863)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
Net loss:(4,571)(1,863)
Comprehensive loss, net of tax, attributable to parent:(4,571)(1,863)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: